FGF21 and metabolic dysfunction-associated steatotic liver disease: Baseline FGF21 concentrations were higher in NAFLD (200 ± 35 pg/mL, 2.2‐fold increase) and highest in cirrhosis (258 ± 46 pg/mL, 2.9‐fold increase, p = 0.005, Table 2).